GATC Health Experts Featured in Two High-Profile Panels at BIO International 2026

July 7, 2026 — GATC Health, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery and development, recently made a significant impact at the BIO International Convention (#BIO2026) in San Diego. Two of GATC’s key thought leaders were invited to share the stage with prominent global industry executives, showcasing the company’s disruptive AI innovations to a record-breaking crowd of 22,000 participants spanning the biotech, pharma, finance, and insurance sectors.  

Panel 1: “In AI We Trust? The Shift from Calculator to Collaborator”

Vaishnavi Narayan, GATC Health’s Head of AI Engineering, took the stage alongside top-tier industry leaders to discuss how artificial intelligence is fundamentally reshaping the biotechnology landscape. The discussion focused on the evolution of AI from a mere processing tool into an indispensable, collaborative partner in scientific discovery.  

Featured Panelists:

Vaishnavi Narayan – Head of AI Engineering, GATC Health   

Faisal Khan, PhD — Corporate Vice President, AI and Analytics, Novo Nordisk

Tom Chittenden, PhD — Chief Technology Officer, ProFound Therapeutics

Henry van den Bedem, PhD — Chief Technical Officer, Expedition Medicines

Simon Burns — Co-Founder and CEO, Vial

Ryan Flinn — AI Correspondent, BiotechTV (moderator)

Panel 2: “Breaking Through the Noise: Building Marketable AI Platforms in Biotech”

Tyrone Lam, GATC Health’s Chief Business Officer, provided pointed, actionable insights on how to cut through industry hype and deliver commercially viable, high-value AI solutions. Lam highlighted GATC’s commercial traction, focusing on the proprietary Derisq™ AI Report and the company’s exclusive clinical trial finance insurance partnership with MCI and Lloyd’s of London—the world’s largest insurance marketplace.  

Featured Panelists:

Tyrone Lam – Chief Business Officer, GATC Health   

Ann Beliën, PhD — Chief Executive Officer and Founder, Rejuvenate Biomed

Tristan Hunt MD — Partner, Averin Capital

Michalis Papadakis, PhD — CEO & Co-Founder, Brainomix

Tomas Philipson, PhD —Former Chairman of the White House Council of Economic Advisors

Driving Commercial Momentum

Beyond the high-profile speaking engagements, GATC Health hosted a high volume of strategic meetings with potential and existing partners, customers, and collaborators at the GATC Health station within the Biocom California booth.  “The momentum around our technology is palpable,” noted GATC’s Tyrone Lam. “We are actively following up on many exciting opportunities and partnerships that emerged from this landmark event.”